Potassium Phosphate, Tribasic → tert-Butyl 4-(4-cyclopropyl-1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-imidazol-2-yl)piperidine-1-carboxylate
반응식
Br[C:2]1[N:3]=[C:4]([CH:16]2[CH2:21][CH2:20][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:18][CH2:17]2)[N:5]([CH2:7][CH2:8][O:9][CH:10]2[CH2:15][CH2:14][CH2:13][CH2:12][O:11]2)[CH:6]=1.[CH:29]1(B(O)O)[CH2:31][CH2:30]1.C1(P(C2CCCCC2)C2CCCCC2)CCCCC1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>C1(C)C=CC=CC=1.O.C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[CH:29]1([C:2]2[N:3]=[C:4]([CH:16]3[CH2:21][CH2:20][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:18][CH2:17]3)[N:5]([CH2:7][CH2:8][O:9][CH:10]3[CH2:15][CH2:14][CH2:13][CH2:12][O:11]3)[CH:6]=2)[CH2:31][CH2:30]1참가 물질
8
반응물 4
생성물 1
시약·촉매·용매 3
실험 절차
Add tert-butyl 4-(4-bromo-1-(2-(tetrahydro-2H-pyran-2-yloxy)ethyl)-1H-imidazol-2-yl)piperidine-1-carboxylate (1.82 g, 3.97 mmol), cyclopropylboronic acid (0.44 g, 1.3 eq), tricyclohexylphosphine (0.11 g, 0.1 eq), and potassium phosphate (2.95 g, 3.5 eq) in toluene (18 mL) and water (0.9 mL). Degas with nitrogen for 5 minutes. Add palladium acetate (0.045 g, 0.05 eq) and heat at 90° C. overnight. Stop heating after 12 hrs. Dilute with water then extract with ethyl acetate three times. Dry over anhydrous magnesium sulfate and concentrate in vacuo. Purify by silica gel chromatography, eluting with 0-20-50% ethyl acetate/hexanes, then with 1-3-5-7% methanol/dichloromethane, to give the title compound (0.61 g, 37%). MS (ES) m/z=420 [M]+.
후처리
- customDegas with nitrogen for 5 minutes
- temperatureStop heating after 12 hrs
- extractionthen extract with ethyl acetate three times
- dry with materialDry over anhydrous magnesium sulfate
- concentrationconcentrate in vacuo
- customPurify by silica gel chromatography
- washeluting with 0-20-50% ethyl acetate/hexanes
출처 및 근거
- ORD 기록
- ord-b0276ffa2b1b4c7791fab89acf5d0a82
- 출처 데이터셋
- uspto-grants-2013_05
- 특허 번호
- US08436002B2
반응 노트
불러오는 중…